Skip to main content
. 2019 Dec 6;2019(1):426–432. doi: 10.1182/hematology.2019000073

Table 1.

Major microvascular and nonthrombotic manifestations of APS

Microvascular manifestations
 Renal (aPL nephropathy)
  Acute—thrombotic microangiopathy
  Chronic (ie, fibrous intimal hyperplasia, focal cortical atrophy, tubular thyroidization, glomerular ischemia, interstitial fibrosis, tubular atrophy, organized thrombi with or without recanalization)
 Pulmonary (diffuse alveolar hemorrhage)
 Cardiac (microvascular disease)
 Dermatologic (livedo with/without skin ulcers)
Nonthrombotic manifestations
 Thrombocytopenia
  Immune mediated
  Thrombotic microangiopathy related
 Hemolytic anemia
  Immune mediated
  With schistocytes and thrombotic microangiopathy
 Cardiac valve vegetations or thickening
 Neurologic*
  Cognitive dysfunction in the absence of stroke
  Subcortical white matter changes
*

Due to multiple mechanisms, including small vessel ischemic events and the direct pathogenic role of aPL.